Note: Ingredients listed on restricted chemical lists
EC/CAS
119-61-9
Name of the chemical
Benzophenon (2022/692)
Concentration
1-10 30-60 1428-37- 1-5 75-650 1-5 104-T6 1-5
General Information
Revision date
2004-11-29
Product name
Riston
CAS No.
119-61-9
Icons in SDS
Company Information
company name
ht
Section 2
SECTION 2: Hazards identification
- Continued) hematological effects in humans aftar being purposely exposed to Acetone by inhalation. Repeated ani/or prolonged | smposura by skin contact with Acetone may cause defatting of | the alin with itching, redness or rash. Signifdesnt skin ' permeation, and syttemic toxicity, after contact appears | unlikely. There are no reports of human sensitization, Eye contact with Acetone may cause eye irritation with tearing, | pain or blurrad vision, Inhalation or ingestion of Acatons may cause central nervous system depression with 4itrdiena, confusion, inceordination, drowsiness or Undoreclowmmess: or sen-specifile affacte such headacha, nausea and weakneas. ACRYLATEA ! Skin contact may cause alight to moderate isritant. Aleo may ! cause allergic reaction. Eye contact may cause slight irritation, Inhalation of mist ox vapor may cause i respiratory tract irritation. There is no information available for ingestion. BRT i This compound may cause akin, sya, nose and throat ' irritation. It may cause allergic akin taghes. Ingeetion i may cause nausea, headacha, or weakness, porcibly :a | progressing to severe stemach cramps, dizziness, confusian me cog and loss of conscliouness.” Liver and kidney changes and meet ay | ey effects, on ‘thd blood Hlecd' clotting system with sasy I brudedag or bleeding may occur upon ingestion. wee | BENZOPHENONE' - ; fe we ts | Skin contact may initially inolude: skin irritation with ‘ | discomfort or rash. fvidence from animal testing suggests that akin permeation can occur in amounte capable of | produciag the effects of systemic toxicity. There are no | feports of human sensitization. Eye contact with high. concentrations of vapora from heated banzophenone may | include: aye irritation with discemfort, tearing, or blurring of vision. Inhalation of high concentrations of vapors from heated banzophenona may include: inritatian of tha upper respiratory passages, with coughing and aiscomfort. tn TAOL Skin contact may initially include: skin irritation with discomfort or rash. Eye contact may initially include; Eye irritation with digeemfort, tearing, ox blurring of vision. Inhalation may initially inélude: irritation of tha upper respiratory passages; temporary nervous system depression | with ansesthetic affects such as dizziness, headacha, ' confusion, inceordinatdon, and loga of censclousnass); or H nonapecifia discomfort, such as nausea, headache, or ! weakness, Ingestion may initially inolude: Irritation af mucosal surfacea; ox nonspecific discomfort, such ag nawaean, headache, or weakness. Data to avaluate the skin parmaation | Print Date: 12 - 09 - 2004 | ' P. Baa“ BAS CwwdoLod fuFont Paga 4 Material Safety Data sheet (HMZARDS IPENTIFICATION - Continued) hazard of this compound are insuffielent. Thera are H inconclusive or unverified reports of human sensitisation. i Individuals with premtisting diseases of the central nervous ; system way bave increaged susceptibility to tha toxicity of excagaive exposurad, 2-ETHYLAEXANOL i Prolonged or repeated siin contact can rasult in defatcing and drying of the skin which may reanult in skin Irritation i with discomfort or rash. Skin permeation may ongur in ameunte enpable of produging the effects of systemic | toxicity. Eys contact with vapor may reault in irritation | with discomfort, tearing, or blurred vision. The Jiquid is | tevarly irritating to the eyas. Inhalation may teaswit in | irritation of the upper respiratory passages. Inhalation or ! ingestion may result in nonspecific discomfort, such ag | nausea, headache, ar weakness; or temporary nerveus system depression with ansesthetic effects such as dizziness, headache, confusion, incoordination, and loss of consciousness. Individuals with preexisting disenses of the skin, eyes or respiratery syetem may have increased ausceptibility to the toxicity of axcassive exposures. NO INFORMATION AVATLASLE OO TH OTHERS, COMPONERNTS , “ id " ‘ mo a . LE tg carcinoganidity information , ” ; ‘ if Nona of the components present. in’ this material at concehtration# tr 4 equal